Surgical Treatment of Absent Pulmonary Valve Syndrome Associated With Bronchial Obstruction

John W. Brown, Mark Ruzmetov, Palaniswamy Vijay, Mark D. Rodefeld, Mark W. Turrentine

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Background: Absent pulmonary valve syndrome (APVS) is a relatively rare anomaly that is usually associated with a ventricular septal defect and a restrictive pulmonary annulus with severe pulmonary regurgitation. The to-and-fro flow across the right ventricular outflow tract produces enormously dilated and pulsatile pulmonary arteries (PAs) that cause severe respiratory distress and tracheomalacia by compression of the trachea and primary bronchi. This retrospective study summarizes our 20-year experience of surgical treatment in patients with APVS. Methods: Between 1984 and 2005, 20 patients underwent repair of APVS using a valved conduit (n = 9), transannular patch (TAP) insertion alone (n = 5), or TAP with monocusp valve (n = 6) with PA reduction arterioplasty. Median age was 7 months (range, 6 days to 9 years). Results: There were one perioperative and two late deaths. All deaths were related to airway complications. Survival was 90% at 1 year and 85% at 10 and 15 years. In a multivariate analysis only preoperative ventilator dependency was associated with a worse outcome (p = 0.02). Follow-up was available in 18 operative survivors (mean follow-up, 7.3 ± 5.2 years). Six patients (33%) underwent reoperation for pulmonary valve incompetence and right ventricular dysfunction. Three patients (17%) had episodic bronchospasm of mild to moderate severity that were responsive to sympathomimetic bronchodilators. Conclusions: Morbidity associated with perioperative respiratory complications and ventilator dependency due to underlying tracheobronchomalacia is an important problem in patients with APVS. These infants may require multiple hospitalizations for recurrent respiratory infections secondary to their tracheobronchomalacia. Complete repair with a valved conduit and reduction pulmonary arterioplasty at the onset of symptoms and a definitive diagnosis is our procedure of choice for infants with APVS. With this approach, the airway can be optimized to give the best patient outcome.

Original languageEnglish (US)
Pages (from-to)2221-2226
Number of pages6
JournalAnnals of Thoracic Surgery
Volume82
Issue number6
DOIs
StatePublished - Dec 1 2006

Fingerprint

Pulmonary Valve
Tracheobronchomalacia
Pulmonary Valve Insufficiency
Mechanical Ventilators
Pulmonary Artery
Therapeutics
Tracheomalacia
Right Ventricular Dysfunction
Bronchial Spasm
Lung
Sympathomimetics
Ventricular Heart Septal Defects
Bronchodilator Agents
Bronchi
Trachea
Reoperation
Respiratory Tract Infections
Survivors
Hospitalization
Multivariate Analysis

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Surgical Treatment of Absent Pulmonary Valve Syndrome Associated With Bronchial Obstruction. / Brown, John W.; Ruzmetov, Mark; Vijay, Palaniswamy; Rodefeld, Mark D.; Turrentine, Mark W.

In: Annals of Thoracic Surgery, Vol. 82, No. 6, 01.12.2006, p. 2221-2226.

Research output: Contribution to journalArticle

@article{0ab7da004afb4c5e96d19a1f7b08b60d,
title = "Surgical Treatment of Absent Pulmonary Valve Syndrome Associated With Bronchial Obstruction",
abstract = "Background: Absent pulmonary valve syndrome (APVS) is a relatively rare anomaly that is usually associated with a ventricular septal defect and a restrictive pulmonary annulus with severe pulmonary regurgitation. The to-and-fro flow across the right ventricular outflow tract produces enormously dilated and pulsatile pulmonary arteries (PAs) that cause severe respiratory distress and tracheomalacia by compression of the trachea and primary bronchi. This retrospective study summarizes our 20-year experience of surgical treatment in patients with APVS. Methods: Between 1984 and 2005, 20 patients underwent repair of APVS using a valved conduit (n = 9), transannular patch (TAP) insertion alone (n = 5), or TAP with monocusp valve (n = 6) with PA reduction arterioplasty. Median age was 7 months (range, 6 days to 9 years). Results: There were one perioperative and two late deaths. All deaths were related to airway complications. Survival was 90{\%} at 1 year and 85{\%} at 10 and 15 years. In a multivariate analysis only preoperative ventilator dependency was associated with a worse outcome (p = 0.02). Follow-up was available in 18 operative survivors (mean follow-up, 7.3 ± 5.2 years). Six patients (33{\%}) underwent reoperation for pulmonary valve incompetence and right ventricular dysfunction. Three patients (17{\%}) had episodic bronchospasm of mild to moderate severity that were responsive to sympathomimetic bronchodilators. Conclusions: Morbidity associated with perioperative respiratory complications and ventilator dependency due to underlying tracheobronchomalacia is an important problem in patients with APVS. These infants may require multiple hospitalizations for recurrent respiratory infections secondary to their tracheobronchomalacia. Complete repair with a valved conduit and reduction pulmonary arterioplasty at the onset of symptoms and a definitive diagnosis is our procedure of choice for infants with APVS. With this approach, the airway can be optimized to give the best patient outcome.",
author = "Brown, {John W.} and Mark Ruzmetov and Palaniswamy Vijay and Rodefeld, {Mark D.} and Turrentine, {Mark W.}",
year = "2006",
month = "12",
day = "1",
doi = "10.1016/j.athoracsur.2006.07.022",
language = "English (US)",
volume = "82",
pages = "2221--2226",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Surgical Treatment of Absent Pulmonary Valve Syndrome Associated With Bronchial Obstruction

AU - Brown, John W.

AU - Ruzmetov, Mark

AU - Vijay, Palaniswamy

AU - Rodefeld, Mark D.

AU - Turrentine, Mark W.

PY - 2006/12/1

Y1 - 2006/12/1

N2 - Background: Absent pulmonary valve syndrome (APVS) is a relatively rare anomaly that is usually associated with a ventricular septal defect and a restrictive pulmonary annulus with severe pulmonary regurgitation. The to-and-fro flow across the right ventricular outflow tract produces enormously dilated and pulsatile pulmonary arteries (PAs) that cause severe respiratory distress and tracheomalacia by compression of the trachea and primary bronchi. This retrospective study summarizes our 20-year experience of surgical treatment in patients with APVS. Methods: Between 1984 and 2005, 20 patients underwent repair of APVS using a valved conduit (n = 9), transannular patch (TAP) insertion alone (n = 5), or TAP with monocusp valve (n = 6) with PA reduction arterioplasty. Median age was 7 months (range, 6 days to 9 years). Results: There were one perioperative and two late deaths. All deaths were related to airway complications. Survival was 90% at 1 year and 85% at 10 and 15 years. In a multivariate analysis only preoperative ventilator dependency was associated with a worse outcome (p = 0.02). Follow-up was available in 18 operative survivors (mean follow-up, 7.3 ± 5.2 years). Six patients (33%) underwent reoperation for pulmonary valve incompetence and right ventricular dysfunction. Three patients (17%) had episodic bronchospasm of mild to moderate severity that were responsive to sympathomimetic bronchodilators. Conclusions: Morbidity associated with perioperative respiratory complications and ventilator dependency due to underlying tracheobronchomalacia is an important problem in patients with APVS. These infants may require multiple hospitalizations for recurrent respiratory infections secondary to their tracheobronchomalacia. Complete repair with a valved conduit and reduction pulmonary arterioplasty at the onset of symptoms and a definitive diagnosis is our procedure of choice for infants with APVS. With this approach, the airway can be optimized to give the best patient outcome.

AB - Background: Absent pulmonary valve syndrome (APVS) is a relatively rare anomaly that is usually associated with a ventricular septal defect and a restrictive pulmonary annulus with severe pulmonary regurgitation. The to-and-fro flow across the right ventricular outflow tract produces enormously dilated and pulsatile pulmonary arteries (PAs) that cause severe respiratory distress and tracheomalacia by compression of the trachea and primary bronchi. This retrospective study summarizes our 20-year experience of surgical treatment in patients with APVS. Methods: Between 1984 and 2005, 20 patients underwent repair of APVS using a valved conduit (n = 9), transannular patch (TAP) insertion alone (n = 5), or TAP with monocusp valve (n = 6) with PA reduction arterioplasty. Median age was 7 months (range, 6 days to 9 years). Results: There were one perioperative and two late deaths. All deaths were related to airway complications. Survival was 90% at 1 year and 85% at 10 and 15 years. In a multivariate analysis only preoperative ventilator dependency was associated with a worse outcome (p = 0.02). Follow-up was available in 18 operative survivors (mean follow-up, 7.3 ± 5.2 years). Six patients (33%) underwent reoperation for pulmonary valve incompetence and right ventricular dysfunction. Three patients (17%) had episodic bronchospasm of mild to moderate severity that were responsive to sympathomimetic bronchodilators. Conclusions: Morbidity associated with perioperative respiratory complications and ventilator dependency due to underlying tracheobronchomalacia is an important problem in patients with APVS. These infants may require multiple hospitalizations for recurrent respiratory infections secondary to their tracheobronchomalacia. Complete repair with a valved conduit and reduction pulmonary arterioplasty at the onset of symptoms and a definitive diagnosis is our procedure of choice for infants with APVS. With this approach, the airway can be optimized to give the best patient outcome.

UR - http://www.scopus.com/inward/record.url?scp=33751172534&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751172534&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2006.07.022

DO - 10.1016/j.athoracsur.2006.07.022

M3 - Article

C2 - 17126138

AN - SCOPUS:33751172534

VL - 82

SP - 2221

EP - 2226

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 6

ER -